Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT00879203
LO5 study: The investigators are inviting a new group of youth (ages 7-16) who have been recently diagnosed with type 1 diabetes and their non-diabetic siblings. These youth will complete cognitive tests and a MRI scan of the brain. This scan uses strong magnets to obtain pictures and does not involve any radiation or injections. The investigators will recruit patients within three months of their diagnosis date. The study entails 1 study visit that lasts 3.5 hours. Evening and weekend times are available. The investigators plan to enroll 135 participants.
HY5 study: The investigators are inviting a cohort of youth and young adults (ages 9-21) with type 1 diabetes and their non-diabetic siblings for a follow-up to a study they have already completed. This group of people will complete several memory and thinking tests along with several MRI scans of their brain, just as they did at their previous visits. The investigators plan to enroll 150 participants.
Looking for future studies?
Notify Me7 year–16 year
All sexes
Observational
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
LO5:
Inclusion criteria
for Participants with Type 1 Diabetes:
Inclusion criteria
for Participants without Type 1 Diabetes:
Exclusion criteria
for Participants with Type 1 Diabetes:
Exclusion criteria
for Participants without Type 1 Diabetes:
HY5: Must have been a participant in our earlier study.
Washington University School of Medicine
Other
Glycemic Control, Brain Structure and Cognition in Youth With T1DM
Acronym: LO5/HY5
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07070752
Type 1 Diabetes Mellitis
Chelyabinsk, Russia
View Trial DetailsNCT00916838
Type 1 Diabetes Mellitis
View Trial DetailsNCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial DetailsNCT07226583
Autoimmune Diseases, Behavior
Palo Alto, California, United States
View Trial Details